SCHEMBL10122121

SCHEMBL10122121

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CN(C)C(=O)N2C(C)CCCC2C)n[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.54
ALDH1A1 P00352 3/20 0.34
TSHR P16473 1/20 0.34
ACE P12821 3/20 0.33
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
CCR4 P51679 2/20 0.32
MAPT P10636 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
GAA P10253 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
RIPK1 Q13546 1/20 0.31
SCN1A P35498 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122281 0.88 GHSR (0.56) GHSRALDH1A1TSHRCCR4MAPT
SCHEMBL10122191 0.88 GHSR (0.56) GHSRALDH1A1TSHRACECACNA1G
SCHEMBL1709651 0.88 GHSR (0.56) GHSRALDH1A1TSHRCCR4MAPT
SCHEMBL1709563 0.87 GHSR (0.60) GHSRALDH1A1CCR4GAASCN1A
SCHEMBL10122273 0.86 GHSR (0.59) GHSRALDH1A1TSHRCCR4GAA
SCHEMBL10122124 0.86 GHSR (0.54) GHSRALDH1A1TSHRGAAKMT2A
SCHEMBL10121891 0.85 GHSR (0.56) GHSRALDH1A1TSHRGAASCN1A
SCHEMBL1709555 0.85 GHSR (0.54) GHSRALDH1A1TSHRMEN1KMT2A
SCHEMBL1709625 0.85 GHSR (0.61) GHSRALDH1A1TSHRCCR4GAA
SCHEMBL10122280 0.84 GHSR (0.54) GHSRALDH1A1TSHRCCR4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885ALDH1A1 3182/4885TSHR 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.